Simulect 20 mg/5mL (Basiliximab INJECTION, POWDER, FOR SOLUTION) 20 mg/5mL

Simulect 20 mg/5mL is a powder for solution injection used in medical settings. This medication, containing basiliximab, is often utilized in specific therapeutic contexts. Learn more about its uses and effects.

Strength

20 mg/5mL

Pack Size

1 VIAL, SINGLE-USE in 1 CARTON (0078-0331-84) / 5 mL in 1 VIAL, SINGLE-USE

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Simulect 20 mg/5mL, containing the active ingredient basiliximab, is typically used in medical settings to support certain immune-related treatments. It is often administered intravenously to help manage conditions where immune modulation is required. What is Simulect used for? Primarily, it is utilized in specific therapeutic protocols to aid in immune system regulation.

Side Effects

When administered as directed, Simulect 20 mg/5mL may help modulate immune responses. Common effects can include temporary changes in immune activity. It is important to monitor for any unusual reactions and consult healthcare professionals as needed.

Precautions & Warnings

Simulect 20 mg/5mL should be handled with care, ensuring proper storage and preparation. It is crucial to follow medical guidelines for administration and to be aware of potential sensitivities or allergies. Always use under professional supervision.

Avoid Interactions

Simulect 20 mg/5mL may interact with other medications, particularly those affecting the immune system. It is important to disclose all current medications to healthcare providers to avoid potential interactions. Alcohol and certain supplements may also impact its effects.

Frequently Asked Questions

Simulect is used in medical settings to support immune-related treatments, often in specific therapeutic protocols.

Simulect is administered intravenously as a powder for solution injection.

Common effects may include temporary changes in immune activity. Always monitor for unusual reactions.

Simulect may interact with other medications, especially those affecting the immune system. Consult healthcare providers for guidance.

Handle Simulect with care, follow medical guidelines for administration, and be aware of potential allergies or sensitivities.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.